Predictive Technology Group Inc
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing servic… Read more
Predictive Technology Group Inc (PRED) - Net Assets
Latest net assets as of March 2021: $31.87 Million USD
Based on the latest financial reports, Predictive Technology Group Inc (PRED) has net assets worth $31.87 Million USD as of March 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($66.96 Million) and total liabilities ($35.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $31.87 Million |
| % of Total Assets | 47.6% |
| Annual Growth Rate | 8.36% |
| 5-Year Change | 21.24% |
| 10-Year Change | N/A |
| Growth Volatility | 44.35 |
Predictive Technology Group Inc - Net Assets Trend (2016–2020)
This chart illustrates how Predictive Technology Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Predictive Technology Group Inc (2016–2020)
The table below shows the annual net assets of Predictive Technology Group Inc from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-06-30 | $54.92 Million | -51.20% |
| 2019-06-30 | $112.54 Million | +58.12% |
| 2018-06-30 | $71.17 Million | +70.53% |
| 2017-06-30 | $41.74 Million | -7.87% |
| 2016-08-31 | $45.30 Million | +13.71% |
| 2016-06-30 | $39.84 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Predictive Technology Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12686003700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2020)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $299.60K | 0.54% |
| Other Components | $181.86 Million | 328.92% |
| Total Equity | $55.29 Million | 100.00% |
Predictive Technology Group Inc Competitors by Market Cap
The table below lists competitors of Predictive Technology Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Empresas Cablevisión S.A.B. de C.V
MX:CABLECPO
|
$25.58K |
|
FRANK'S INTERN
BE:FK2
|
$25.61K |
|
CMIG3F
SA:CMIG3F
|
$25.62K |
|
Les Constructeurs Du Bois SA
PA:MLLCB
|
$25.62K |
|
Saudi Egyptian Investment & Finance
EGX:SEIG
|
$25.56K |
|
ANHUI CONCH -H-
MU:AQE
|
$25.54K |
|
Vee S.A.
WAR:VEE
|
$25.51K |
|
CHUNGTAI RESOURCE Technology CORP.
TW:6923
|
$25.47K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Predictive Technology Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 112,775,743 to 55,290,305, a change of -57,485,438 (-51.0%).
- Net loss of 85,897,009 reduced equity.
- New share issuances of 480,000 increased equity.
- Other factors increased equity by 27,931,571.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-85.90 Million | -155.36% |
| Share Issuances | $480.00K | +0.87% |
| Other Changes | $27.93 Million | +50.52% |
| Total Change | $- | -50.97% |
Book Value vs Market Value Analysis
This analysis compares Predictive Technology Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-06-30 | $0.11 | $0.00 | x |
| 2015-06-30 | $0.04 | $0.00 | x |
| 2016-06-30 | $0.24 | $0.00 | x |
| 2017-06-30 | $0.21 | $0.00 | x |
| 2018-06-30 | $0.33 | $0.00 | x |
| 2019-06-30 | $0.42 | $0.00 | x |
| 2020-06-30 | $0.19 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Predictive Technology Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -155.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -351.44%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.52x
- Recent ROE (-155.36%) is below the historical average (-113.01%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -71.37% | 0.00% | 0.00x | 1.00x | $-13.77K |
| 2007 | -350.88% | 0.00% | 0.00x | 1.00x | $-29.15K |
| 2015 | -350.88% | 0.00% | 0.00x | 1.00x | $-29.15K |
| 2016 | -41.65% | -22059.05% | 0.00x | 1.00x | $-20.59 Million |
| 2016 | -0.28% | -168.89% | 0.00x | 1.00x | $-4.66 Million |
| 2017 | -14.77% | -238.78% | 0.06x | 1.03x | $-10.35 Million |
| 2018 | -18.18% | -77.97% | 0.19x | 1.25x | $-20.09 Million |
| 2019 | -13.68% | -35.46% | 0.30x | 1.27x | $-26.70 Million |
| 2020 | -155.36% | -351.44% | 0.29x | 1.52x | $-91.43 Million |
Industry Comparison
This section compares Predictive Technology Group Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Predictive Technology Group Inc (PRED) | $31.87 Million | -71.37% | 1.10x | $25.58K |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |